XML 68 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)
In Thousands, unless otherwise specified
 9 Months Ended
Sep. 29, 2012
Oct. 01, 2011
Operating Activities:    
Net income $ 201,337 $ 184,601
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation, amortization and accretion 47,146 37,743
Stock-based compensation 12,858 10,524
Decrease in allowance for returns - net of inventory in transit (2,929) (717)
Loss on disposal of assets 1,473 1,093
Impairment loss 256  
Equity in income of joint venture (815) (54)
Distribution from joint venture   2,226
(Decrease) increase in allowance for doubtful accounts (3,047) 1,173
Excess tax benefits from stock-based compensation (11,223) (9,723)
Deferred income taxes and other 4,836 14,808
Contingent consideration revaluation (3,585)  
Changes in operating assets and liabilities:    
Accounts receivable 41,043 (10,817)
Inventories (78,487) (143,535)
Prepaid expenses and other current assets (1,866) (11,449)
Accounts payable (28,586) 9,465
Accrued expenses (50,141) (12,333)
Income taxes payable 40,231 9,724
Net cash provided by operating activities 168,501 82,729
Investing Activities:    
Additions to property, plant and equipment (59,710) (70,237)
Increase in intangible and other assets (4,980) (13,913)
Purchase of securities available for sale   (222)
Sales/maturities of securities available for sale   111
Proceeds from the sale of property, plant and equipment 21 21,319
Net change in restricted cash 6,903 (7,344)
Business acquisitions-net of cash acquired (229,151)  
Net cash used in investing activities (286,917) (70,286)
Financing Activities:    
Acquisition of common stock (205,631) (204,430)
Distribution of noncontrolling interest earnings (4,406) (3,772)
Excess tax benefits from stock-based compensation 11,223 9,723
Borrowings on notes payable 399,198 12,881
Payments on notes payable (235,688) (7,055)
Common stock issued upon legal settlement   7,833
Proceeds from exercise of stock options 5,279 8,218
Net cash used in financing activities (30,025) (176,602)
Effect of exchange rate changes on cash and cash equivalents 3,780 2,520
Net decrease in cash and cash equivalents (144,661) (161,639)
Cash and cash equivalents:    
Beginning of period 287,498 392,794
End of period $ 142,837 $ 231,155